BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Glucagon-like peptide-1 receptor agonists
1
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
11/29/2024 8:40:08 AM | Browse: 51 | Download: 130
2
Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetes
10/16/2024 10:38:58 AM | Browse: 55 | Download: 167
3
Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases
9/20/2024 8:50:41 AM | Browse: 50 | Download: 181
4
Effect of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients
8/11/2023 11:04:23 AM | Browse: 188 | Download: 682
5
Semaglutide-eye-catching results
4/12/2023 11:34:59 AM | Browse: 238 | Download: 578
6
Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?
7/5/2022 1:22:29 AM | Browse: 361 | Download: 716
7
Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report
10/29/2021 12:16:54 PM | Browse: 469 | Download: 730
8
Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
9/7/2021 8:15:21 AM | Browse: 606 | Download: 1271
9
Clinical effects of antidiabetic drugs on psoriasis: The perspective of evidence-based medicine
8/9/2021 10:25:22 AM | Browse: 495 | Download: 1003
10
Recent advances in new-onset diabetes mellitus after kidney transplantation
5/6/2021 11:18:51 AM | Browse: 552 | Download: 1118
11
Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
9/11/2020 7:11:20 AM | Browse: 645 | Download: 1105
12
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
8/25/2020 9:16:00 AM | Browse: 735 | Download: 1433
13
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 987 | Download: 1461
14
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
10/11/2016 11:41:00 AM | Browse: 1252 | Download: 1377
15
Incretin-based therapies in prediabetes: Current evidence and future perspectives
12/13/2014 7:02:00 PM | Browse: 1317 | Download: 1891
16
Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation
10/29/2014 7:34:00 PM | Browse: 1121 | Download: 1566
17
Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes
9/1/2014 12:00:00 PM | Browse: 1219 | Download: 1160
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345